ReviewFrontiers in oncology2022

Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1.

Amirali B Bukhari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.